rhG-CSF is associated with an increased risk of metastasis in NSCLC patients following postoperative...
rhG-CSF is associated with an increased risk of metastasis in NSCLC patients following postoperative chemotherapy
About this item
Full title
Author / Creator
Wang, Yong , Fang, Chen , Chen, Renfang , Yuan, Shangkun , Chen, Lin , Qiu, Xiaotong , Qian, Xiaoying , Zhang, Xinwei , Xiao, Zhehao , Wang, Qian , Fu, Biqi , Song, Xiaoling and Li, Yong
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Background Recombinant human granulocyte colony-stimulating factor (rhG-CSF) reduces neutropenia events and is widely used in cancer patients receiving chemotherapy. However, the effects of rhG-CSF on distant organ metastasis (DOM) in non-small-cell lung cancer (NSCLC) patients following postoperative chemotherapy are not clear. Methods A retrospec...
Alternative Titles
Full title
rhG-CSF is associated with an increased risk of metastasis in NSCLC patients following postoperative chemotherapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_033b751fadda43128adc075118bcd415
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_033b751fadda43128adc075118bcd415
Other Identifiers
ISSN
1471-2407
E-ISSN
1471-2407
DOI
10.1186/s12885-022-09850-4
